Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))

H Woopen, J Sehouli, A Davis, Y C Lee, P A Cohen, A Ferrero, N Gleeson, A Jhingran, Y Kajimoto, J Mayadev, M P Barretina-Ginesta, S Sundar, N Suzuki, E van Dorst, F Joly

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The publisher regrets that the survivorship care plan (Fig. 1) of the above article was incomplete. The complete version of the proposed survivorship care plan is now embedded as supplementary material in the article in a printable format. In addition, the author regrets that the details for affiliation “a” were incomplete. The correct affiliation is as listed above. The publisher and author would like to apologise for any inconvenience caused.

Original languageEnglish
Article number102431
JournalCancer Treatment Reviews
Volume109
DOIs
Publication statusPublished - Sept 2022

Fingerprint

Dive into the research topics of 'Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee” [Cancer Treatm. Rev. 107 (2022) 102396] (Cancer Treatment Reviews (2022) 107, (S0305737222000603), (10.1016/j.ctrv.2022.102396))'. Together they form a unique fingerprint.

Cite this